Albert Labs announces Strategic Investment from Cantheon Capital LLC for First In-Human TrialsMindMed Reports Full Year 2022 Financial Results and Business HighlightsCybin to Participate in the Oppenheimer 33rd Annual Healthcare ConferenceNuminus to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023Braxia Scientific Provides Update on Proposed Irwin Transaction; Company Retains Strategic Clinical Assets and Ketamine Numinus Announces Four Peer-Reviewed Publications from its Chief Clinical Officer in 2023Irwin Naturals Signs Letter of Intent to Acquire Braxia ScientificNuminus Wellness Inc. Reports Q1 2023 ResultsIrwin Naturals and Braxia Scientific Announce Partnership for In-Human Clinical Studies Supporting Pharmaceutical CompanNuminus Develops Mushroom Tea for Use in Psychedelic ResearchIs the Psychedelic Sector Poised for a Comeback?!?PSYC + Nucleus Form New Partnership to Develop and Launch Psychedelic FinderWhat You Need to Know About Numinus Wellness…Numinus provides update on acquisition integration and announces new client financing optionsPSYC Corp’s Psychedelic Spotlight Surpasses One Million Page Views for Fourth Consecutive MonthNuminus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022The Psychedelic Sector is Quietly Outperforming the S&P 500PSYC Completes and Publishes 2021 Audited Financials; Will Begin Audit of Q1 & Q2 2022Numinus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022PSYC’s Bonfire Platform Development Progresses; Will Host Free Virtual Community Event on August 29th

Health Canada Reforms Medical Marijuana Regulations

Jul 9, 2015 • 1:55 PM EDT
3 MIN READ  •  By Michael Berger
Share Share - Facebook Share - Twitter

Yesterday, Health Canada announced that licensed producers under the Marihuana for Medical Purposes Regulations (MMPR), can ship unscented and unflavored cannabis oil to registered patients. The licensed producers will be able to start producing and selling cannabis oil after being inspected and approved by Health Canada. One producer said customers could start receiving oil in about two months.

Licensed producers must apply for a Section 56 exemption under the Controlled Drugs and Substances Act to conduct research on extractions. The Section 56 exemption, under the CDSA, states:

“Licensed producers to produce and sell cannabis oil and fresh marijuana buds and leaves in addition to dried marijuana (plant material that can be used to propagate marijuana will not be permitted to be sold by licensed producers to clients). The role of healthcare practitioners in authorizing marijuana for medical purposes does not change.”

Who will benefit from this announcement?

Yesterday, Health Canada said it will allow 18 licensed producers to sell oil as well as dried marijuana originally allowed under new federal regulations. The publicly traded licensed producers in Canada that are levered to this development include:

  • Tweed Marijuana Inc. (TWD) (TWMJF) already applied for a Section 56 exemption and the company is upgrading its facility so they can start extracting once the facility is approved.
  • OrganiGram Holdings Inc. (OGI) (OGRMF) is a licensed producer of medical cannabis through its subsidiary, Organigram Inc., who is a licensed producer of medical marijuana in Canada. Organigram is focused on producing condition specific medical marijuana for patients in Canada. Organigram’s facility is located in Moncton, New Brunswick.
  • Bedrocan Cannabis Corp. (BED) (BNRDF) is in the process of being acquired Tweed Marijuana (announced on June 24th). Bedrocan operates under its Dutch licensor and they are one of the most experienced medical marijuana producers in the world.
  • Mettrum Health Corp. (MT) (MQTRF) is a Toronto-based company and a licensed producer of medical cannabis through its subsidiaries. Mettrum received its first license on November 1, 2013 for its facility in Bowmanville, Ontario. The company received its second license on December 11, 2014 for its facility in Clearview, Ontario.


Prior to this announcement, the MMPR only allowed for the sale of dried cannabis. Canada still has a ban on marijuana infused cookies and brownies, however, this is a step in the right direction. Many experts expect the size of the Canadian marijuana market to double once recreational marijuana is legalized.

We expect this announcement to lead to incremental revenue growth for licensed medical marijuana producers in Canada. This will serve as a catalyst for some of these companies mentioned above and investors should monitor the impact this has on the companies’ top and bottom line.


Important Investor Disclosures:

Technical 420 LLC, and any of its directors, officers, employees, affiliates, or subsidiaries does not accept any form of compensation from companies in return for writing reports on them. Also Technical 420 LLC, and any of its directors, officers, employees, affiliates, or subsidiaries do not hold any stock positions in companies covered by MushroomstocksLLC. All information relied upon for the above report is publically available via various research resources, including third-party sources we consider reliable, but we do not guarantee that any of such information is accurate or complete.  

Share Share - Facebook Share - Twitter


Authored By

Michael Berger

Michael Berger is Managing Partner of StoneBridge Partners, LLC and Founder of Prior to entering the cannabis industry, Michael was an Equity Research Analyst at Raymond James Financial covering the Energy Sector. Michael has been featured in publications such as The Street, Bloomberg, US Money News, and hosts various cannabis events across North America.


Top Stories

Get the Latest Cannabis News & Stock Picks.

Enter your email below to join the official Mushroomstocks newsletter.

 All good -- no spamming here.

The psychedelics sector is starting to take off as smart money begins to position itself across the industry.

Stay updated with all latest updates,upcoming events & much more.